KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA)

Historical Holders from Q3 2022 to Q2 2025

Symbol
KALA on Nasdaq
CUSIP
483119202
Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
7.46M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
3.64M
Holdings value
$17.3M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
28
Number of buys
11
Number of sells
-8
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BAKER BROS. ADVISORS LP 9.99% 0% $11.4M 745K 0% Baker Bros. Advisors LP Oct 2, 2025
Cormorant Asset Management, LP 9.99% $2.05M 609K Cormorant Asset Management, LP Dec 31, 2024
PERCEPTIVE ADVISORS LLC 7.7% $1.89M 544K Perceptive Advisors LLC Sep 4, 2025
Point72 Asset Management, L.P. 6.7% $1.63M 469K Point72 Asset Management, L.P. Sep 4, 2025
SR ONE CAPITAL MANAGEMENT, LLC 5.5% $6.28M 411K SR One Capital Fund II Aggregator, LP Sep 29, 2025
ADAR1 Capital Management, LLC 4.91% $1.01M 299K ADAR1 Capital Management, LLC Dec 31, 2024

Institutional Holders of KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 3.64M $17.3M -$2.66M $4.76 28
2025 Q1 4.14M $23.7M +$3.69M $5.73 26
2024 Q4 3.46M $24M +$9.35M $6.94 29
2024 Q3 2.12M $12.1M +$82.5K $5.70 26
2024 Q2 2.09M $14.8M +$10.4M $7.09 27
2024 Q1 542K $4.29M +$627K $7.97 17
2023 Q4 524K $3.67M +$62.4K $7.00 21
2023 Q3 514K $4.57M +$1.12M $8.90 24
2023 Q2 381K $5.56M +$893K $14.59 26
2023 Q1 319K $4.81M -$2.05M $15.05 22
2022 Q4 324K $12.3M +$12.3M $38.15 27
2022 Q3 90.5K $20K +$20K $0.22 1